(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Edgewise Therapeutics, Inc. Executive Compensation
* In original currency USD
Loading Data
|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Tuesday, April 29th, 2025 | 2023 | Behrad Derakhshan, Ph.D. Chief Operating | 446,667 | 0 | 0 | 184,000 | 0 | 1,756,317 |
| Tuesday, April 29th, 2025 | 2024 | Behrad Derakhshan, Ph.D. Chief Operating | 478,400 | 0 | 394,281 | 310,960 | 7,176 | 2,896,193 |
| Tuesday, April 29th, 2025 | 2023 | Joanne M. Donovan, M.D., Ph.D. Chief Medical Officer | 488,000 | 0 | 0 | 195,200 | 13,200 | 1,716,844 |
| Tuesday, April 29th, 2025 | 2024 | Joanne M. Donovan, M.D., Ph.D. Chief Medical Officer | 507,520 | 0 | 394,281 | 303,497 | 13,800 | 2,924,474 |
| Tuesday, April 29th, 2025 | 2023 | Kevin Koch, Ph.D. President and | 594,880 | 0 | 0 | 297,440 | 13,200 | 3,975,855 |
| Tuesday, April 29th, 2025 | 2024 | Kevin Koch, Ph.D. President and | 618,675 | 0 | 1,225,469 | 442,353 | 13,800 | 7,601,200 |
| Friday, April 26th, 2024 | 2022 | Kevin Koch, Ph.D. President and | 572,000 | 0 | 249,375 | 328,900 | 12,200 | 5,355,544 |
| Friday, April 26th, 2024 | 2023 | Behrad Derakhshan, Ph.D. Chief Business | 446,667 | 0 | 0 | 184,000 | 0 | 1,756,317 |
| Friday, April 26th, 2024 | 2023 | Kevin Koch, Ph.D. President and | 594,880 | 0 | 0 | 297,440 | 13,200 | 3,975,855 |
| Friday, April 26th, 2024 | 2022 | Behrad Derakhshan, Ph.D. Chief Business | 416,000 | 0 | 124,688 | 191,360 | 0 | 2,256,669 |
| Friday, April 26th, 2024 | 2023 | Joanne M. Donovan, M.D., Ph.D. Chief Medical Officer | 488,000 | 0 | 0 | 195,200 | 13,200 | 1,716,844 |
| Friday, April 26th, 2024 | 2022 | Joanne M. Donovan, M.D., Ph.D. Chief Medical Officer | 468,000 | 0 | 249,375 | 215,280 | 12,200 | 2,774,445 |
| Friday, April 28th, 2023 | 2022 | Alan J. Russell, Ph.D. Co-Founder and | 442,000 | 0 | 124,688 | 203,320 | 12,200 | 2,459,315 |
| Friday, April 28th, 2023 | 2021 | Joanne M. Donovan, M.D., Ph.D. Chief Medical Officer | 308,523 | 0 | 0 | 141,214 | 3,750 | 5,169,956 |
| Friday, April 28th, 2023 | 2022 | Joanne M. Donovan, M.D., Ph.D. Chief Medical Officer | 468,000 | 0 | 249,375 | 215,280 | 12,200 | 2,774,445 |
| Friday, April 28th, 2023 | 2021 | Kevin Koch, Ph.D. President and | 524,500 | 0 | 0 | 316,250 | 4,583 | 5,118,573 |
| Friday, April 28th, 2023 | 2021 | Alan J. Russell, Ph.D. Co-Founder and | 410,597 | 0 | 0 | 195,500 | 3,542 | 1,891,500 |
| Friday, April 28th, 2023 | 2022 | Kevin Koch, Ph.D. President and | 572,000 | 0 | 249,375 | 328,900 | 12,200 | 5,355,544 |
| Monday, May 2nd, 2022 | 2021 | Kevin Koch, Ph.D. President and | 524,500 | 0 | 0 | 316,250 | 4,583 | 5,118,573 |
| Monday, May 2nd, 2022 | 2020 | Kevin Koch, Ph.D. President and | 425,000 | 0 | 0 | 255,000 | 0 | 1,690,038 |
| Monday, May 2nd, 2022 | 2021 | Joanne M. Donovan, M.D., Ph.D. Chief Medical Officer | 308,523 | 0 | 0 | 141,214 | 3,750 | 5,169,956 |
| Monday, May 2nd, 2022 | 2020 | Joanne M. Donovan, M.D., Ph.D. Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Monday, May 2nd, 2022 | 2021 | Behrad Derakhshan, Ph.D. Chief Business Officer | 388,194 | 0 | 0 | 184,000 | 3,333 | 2,071,062 |
| Monday, May 2nd, 2022 | 2020 | Behrad Derakhshan, Ph.D. Chief Business Officer | 110,833 | 0 | 0 | 36,318 | 0 | 477,224 |
